The HRT Club and Posterity Health Join Forces to Advance Inclusive Hormonal Healthcare
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- The HRT Club, a leading pioneer of direct-to-consumer hormone replacement therapies, today announced a strategic partnership with Posterity Health, the leader in expert-led, comprehensive men's health. Together, the two companies are creating a more robust and inclusive approach to hormonal health, providing streamlined access to expert care for individuals and couples alike.
The collaboration offers members of The HRT Club a direct pathway to male hormone evaluation and treatment through Posterity Health's best-in-class male management platform that provides both telehealth and in-person care.
Share
'Hormonal health is important to all of us,' said Lauren Darisse, Esq., COO & general counsel of The HRT Club. 'This partnership is the beginning of something truly remarkable. We are totally rewriting the rules of hormonal healthcare and making it accessible to everyone — no gatekeeping, just a system made for our members, by our members.'
The collaboration offers members of The HRT Club a direct pathway to male hormone evaluation and treatment through Posterity Health's best-in-class male management platform that provides both telehealth and in-person care. Posterity Health patients benefit from access to The HRT Club's affordable, member-driven model for FDA-approved hormone therapies, all without the need for insurance or pharmacy benefit managers.
'Too often, men are placed on hormone therapy without ever speaking to a men's health expert. At Posterity Health, we offer more than a prescription — we provide a trusted partner who understands the full picture, uncovers underlying health issues and creates a personalized care plan to help every man feel his best,' said Barrett Cowan, MD, co-founder and chief medical officer of Posterity Health. 'By partnering with The HRT Club, we're giving individuals and couples a more complete, connected and affordable path to care.'
By integrating Posterity Health's male care with HRT Club's existing female hormone care, the partnership fills a long-standing gap in the market: providing coordinated, proactive solutions for couples navigating fertility and midlife health. Many female members of The HRT Club have referred male partners and friends in search of similar support. This partnership is a direct response to their needs and the growing need for expert male care and men's health support.
By offering services that speak to the full spectrum of hormonal health, this partnership expands service offerings, increases member lifetime value and reinforces The HRT Club's position as a trusted, community-driven care model.
About The HRT Club
The HRT Club is on a mission to make hormonal treatments accessible to everyone. Since its launch in April 2024, The HRT Club has quickly become the leading doctor-recommended platform for hormone replacement therapy (HRT). With a network of over 1,400 prescribers and strategic partnerships across the healthcare industry, we are transforming how people access and afford hormonal treatments. Our members enjoy savings of up to 90% on their HRT prescriptions, ensuring that life-changing care is within reach for all who need it. For more information, visit https://thehrtclub.com.
Posterity Health is the leader in expert-led, comprehensive men's health. We provide innovative solutions to optimize hormone levels, address fertility challenges, provide vasectomies and vasectomy reversals and manage long-term health risks, combining cutting-edge technology with expert clinical care. Through our telehealth services, at-home diagnostics and in-person care, Posterity Health is the trusted partner for men at every stage. For more information, visit https://posterityhealth.com/.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2
MOUNTAIN VIEW, Calif., June 17, 2025--(BUSINESS WIRE)--Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of a recent close within an ongoing $20 million Series B2 financing round. The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund, and Golden Seeds. "As we celebrate the addition of these new funds to our investment team, we are also excited to announce the new commercial name for our second product, Ellora™ (formerly Materna Prep), aiming to transform the standard of care in labor and delivery," commented Tracy MacNeal, Chief Executive Officer for Materna Medical "Over 20 of the top hospitals in the US have been incredible partners in the EASE trial for Ellora™, which will be the basis of our FDA De Novo submission this summer." For more information on Materna Medical, visit About Materna Medical Materna Medical is a novel OBGYN platform company defining a $25B market with core technologies addressing unmet needs in women's pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers, and commercial leaders, Materna Medical's mission is to empower women to protect their pelvic health. Our first product, Milli™, is vaginal dilator to support patients suffering from vaginismus and related painful sex. In 2019, the Milli device launched as a wellness trainer and, in 2023, received FDA clearance to sell over the counter, enabling streamlined access to people suffering from vaginismus. Milli outcomes have been studied in a post-market prospective virtual study named POMPOM. Materna's second product, Ellora™, is an investigational device used during labor and is intended to reduce pelvic floor muscle injury during vaginal delivery. This product is being studied in the EASE trial, a large, randomized controlled trial in 20 top US hospitals. Materna aims to transform the standard of care in labor and delivery by protecting pelvic floor health for moms. View source version on Contacts Debbie DonovanHead of Commercial OperationsMaterna Medical, Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of a recent close within an ongoing $20 million Series B2 financing round. The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund, and Golden Seeds. "As we celebrate the addition of these new funds to our investment team, we are also excited to announce the new commercial name for our second product, Ellora™ (formerly Materna Prep), aiming to transform the standard of care in labor and delivery," commented Tracy MacNeal, Chief Executive Officer for Materna Medical "Over 20 of the top hospitals in the US have been incredible partners in the EASE trial for Ellora™, which will be the basis of our FDA De Novo submission this summer." For more information on Materna Medical, visit About Materna Medical Materna Medical is a novel OBGYN platform company defining a $25B market with core technologies addressing unmet needs in women's pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers, and commercial leaders, Materna Medical's mission is to empower women to protect their pelvic health. Our first product, Milli™, is vaginal dilator to support patients suffering from vaginismus and related painful sex. In 2019, the Milli device launched as a wellness trainer and, in 2023, received FDA clearance to sell over the counter, enabling streamlined access to people suffering from vaginismus. Milli outcomes have been studied in a post-market prospective virtual study named POMPOM. Materna's second product, Ellora™, is an investigational device used during labor and is intended to reduce pelvic floor muscle injury during vaginal delivery. This product is being studied in the EASE trial, a large, randomized controlled trial in 20 top US hospitals. Materna aims to transform the standard of care in labor and delivery by protecting pelvic floor health for moms.
Yahoo
an hour ago
- Yahoo
Dental Care of Stamford announces Breakthrough Bite-Based Treatment During Migraine Awareness Month
STAMFORD, CT, June 17, 2025 (GLOBE NEWSWIRE) -- As Migraine Awareness Month shines a spotlight on one of the most debilitating chronic conditions in the world, Dr. Jerry Simon, a leading dental expert in craniofacial pain and neuromuscular dentistry, is offering a fresh perspective on how migraines could be a dental issue hiding in plain sight?Migraines affect more than 35 million Americans annually, often derailing daily life with searing pain, nausea, and visual disturbances. Despite modern medicine's advancements, many patients still struggle to find a sustainable solution, leaving them stuck in a cycle of temporary relief and recurring agony. Dr. Simon believes the answer for many could be closer than they think , right inside their mouth. 'Too many people suffer unnecessarily because the true cause of their pain is being overlooked,' says Dr. Simon. 'What if the root of your migraines isn't neurological, but dental?' The Dental Link to Migraines: An Overlooked Connection Dr. Simon, founder of Dental Care of Stamford and innovator of the FDA-approved Best-Bite Discluder™, is challenging conventional approaches by investigating a common yet often missed culprit: bite imbalances. According to his research and clinical practice, nearly 75% of chronic migraines, neck aches, facial discomfort, and tension headaches stem from misaligned bites also known as malocclusion. This overlooked factor causes the muscles in the jaw and face to overcompensate, leading to inflammation and persistent pain. 'You use your mouth all day—to chew, talk, breathe, even clench unconsciously. If your teeth don't come together properly, your jaw muscles are constantly adjusting, and over time, that stress adds up,' Dr. Simon explains. Quick, Non-Invasive Diagnostic Tool Offers New Path to Relief To pinpoint whether migraines are bite-related, Dr. Simon developed a diagnostic device known as the Best-Bite Discluder™, which helps determine within minutes if a patient's bite is contributing to their head pain. The small, comfortable appliance temporarily disengages the back teeth to relieve pressure. If patients experience immediate relief, even if momentary, it signals that the bite may be the root cause. 'The most powerful moment is watching someone realize that their pain doesn't have to be permanent,' says Dr. Simon. 'If the discluder test helps, it gives us a clear path forward.' Real Stories, Real Relief Former patient S.W., once plagued by chronic migraines and disappointed by countless specialist visits and inconclusive scans, found hope with Dr. Simon. 'I had migraines forever. Undergone endless tests from multiple doctors with no answers. Dr. Simon suggested my teeth could be the issue & then tested my bite. After a few visits, I was already feeling great! He gave me my life back, pain-free!' A Collaborative, Personalized Approach If a bite issue is confirmed, Dr. Simon and his team at Dental Care of Stamford create a customized treatment plan tailored to each patient's unique physiology. This plan may involve bite adjustments, physical therapy, and advanced dental procedures aimed at achieving harmony between the jaw and surrounding muscles - offering lasting relief without reliance on medications or invasive treatments. Raising Awareness, Changing Lives During Migraine Awareness Month, Dr. Simon hopes to educate the public about this little-known yet significant link between dental health and migraines. His goal is to help people who feel like they've exhausted every option and are still searching for answers. 'Migraines are not something people should have to just live with,' says Dr. Simon. 'By identifying and treating the actual source of pain—instead of just masking symptoms - we can truly transform lives.' Schedule Your Consultation Today If you or a loved one has struggled with chronic headaches or migraines, there's no need to wait any longer. Relief could be a simple consultation away. Call (203) 324-6171 or visit CONTACT: Media Contact: Dental Care of Stamford Phone: (203) 324-6171 Email: FrontDesk@ in to access your portfolio
